• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza Virus Hemagglutinin: A Model for Protein N-Glycosylation in Recombinant Escherichia coli

tetano

Editor, Senior Moderator
Intervirology. 2011 Jul 6. [Epub ahead of print]
Influenza Virus Hemagglutinin: A Model for Protein N-Glycosylation in Recombinant Escherichia coli.
Farahmand B, Khodabandeh M, Mahboudi F, Fotouhi F, Saleh M, Barkhordari F, Tabatabaian M, Nasab FP, Kheiri MT.
Source

Department of Virology (Influenza Unit), Pasteur Institute of Iran, Tehran, Iran.
Abstract

Background: The hemagglutinin molecule of influenza virus is considered as an ideal model to study biological processes as well as the effect of glycosylation on the function of glycoproteins. Objectives: The large subunit of the influenza virus A/New Caledonia/20/99 (H1N1) hemagglutinin (HA1) was expressed in recombinant Escherichia coli containing the glycosylation system of Campylobacter jejuni. This viral glycoprotein contains glycosylation motifs recognized by prokaryotic and eukaryotic oligosaccharyltransferases. Methods: In order to express the hemagglutinin large subunit gene, the gene was amplified using reverse transcription polymerase chain reaction (RT-PCR), and it was cloned in pET22b for periplasmic expression. Results: Western blotting and lectin blotting bands confirmed glycosylation of the HA1 in recombinant E. coli. Conclusion: Such a successful accomplishment of hemagglutinin expression in recombinant E. coli can be used to construct carbohydrates in hemagglutinin molecules of different strains in order to produce effective antigens for vaccine and rapid diagnostic kits against new emerging viruses.

Copyright ? 2011 S. Karger AG, Basel.

PMID:
21734350
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/21734350
 
Back
Top Bottom